Skip to main content

Documented contraceptive use after delivery in women with pre-gestational and gestational diabetes in Thailand: a single center study

Abstract

Purpose

To determine the contraceptive prevalence rate in postpartum women with diabetes complicating pregnancy.

Materials and methods

This retrospective study included women diagnosed with gestational diabetes (GDM) and pre-existing diabetes (PDM) who delivered at Siriraj Hospital during January 2016 to December 2019. Contraceptive use during the 6 months postpartum period was reviewed and compared between the diabetes groups.

Results

A total of 1539 women were enrolled, including 1466 women with GDM and 73 women with PDM. The overall contraceptive prevalence rate was 78.7%, which was not different between the diabetes groups (PDM 75.4% vs. GDM 78.9%, OR 0.95; 95% CI 0.83–1.09). The commonly used methods were sterilization (34.8%), progestin injection (15.2%) and condom (10.9%). Sterilization was more prevalent in PDM (PDM 56.2% vs. GDM 33.8%, OR 1.66; 95% CI 1.34–2.06) and a modern reversible method was infrequently used in women with PDM (PDM 19.2% vs. GDM 45.1%, OR 0.42; 95% CI 0.26–0.68). Among non-sterilization, the odds of contraceptive use was significantly lower in PDM (OR 0.64, 95% CI 0.43–0.95).

Conclusions

Women with DM-complicated pregnancy frequently used contraception after delivery. However, the rate of modern contraceptive use among non-sterilized women was lower in those with PDM and the chosen methods were still inappropriate. Our findings highlight potential opportunities to improve contraceptive care and the need to promote the use of highly effective methods, seeking to minimize barriers for modern reversible contraceptive accessing.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

Availability of data and materials

They are available upon request.

References

  1. International Diabetes Federation. Thailand diabetes report 2010–2045. IDF: Brussels, Belgium, 2019. https://diabetesatlas.org/data/en/country/196/th.html.

  2. Feig DS, Berger H, Donovan L, Godbout A, Kader T, Keely E, et al. Diabetes and Pregnancy. Can J Diabetes. 2018;42(Suppl 1):S255–82.

    Article  Google Scholar 

  3. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London, England). 2009;373(9677):1773–9.

    CAS  Article  Google Scholar 

  4. Bernstein J, Lee-Parritz A, Quinn E, Ameli O, Craig M, Heeren T, et al. After gestational diabetes: impact of pregnancy interval on recurrence and type 2 diabetes. BioResearch Open Access. 2019;8(1):59–64.

    CAS  Article  Google Scholar 

  5. Management of Diabetes in Pregnancy. Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S200–10.

    Google Scholar 

  6. Alexopoulos AS, Blair R, Peters AL. Management of preexisting diabetes in pregnancy: a review. JAMA. 2019;321(18):1811–9.

    Article  Google Scholar 

  7. National Statistical Office Thailand. Thailand Multiple Indicator Cluster Survey 2019, Survey Findings Report. National Statistical Office of Thailand, 2020. https://www.unicef.org/thailand/media/5146/file/Multiple%20Indicator%20Cluster%20Survey%202019.pdf.

  8. Britton LE, Hussey JM, Berry DC, Crandell JL, Brooks JL, Bryant AG. Contraceptive use among women with prediabetes and diabetes in a US National Sample. J Midwifery Womens Health. 2019;64(1):36–45.

    PubMed  Google Scholar 

  9. Schwarz EB, Braughton MY, Riedel JC, Cohen S, Logan J, Howell M, et al. Postpartum care and contraception provided to women with gestational and preconception diabetes in California’s Medicaid program. Contraception. 2017;96(6):432–8.

    Article  Google Scholar 

  10. Shawe J, Smith P, Stephenson J. Use of contraception by women with type 1 or type 2 diabetes mellitus: “it’s funny that nobody really spoke to me about it.” Eur J Contracept Reprod Health Care. 2011;16(5):350–8.

    Article  Google Scholar 

  11. Rosenthal EW, Easter SR, Morton-Eggleston E, Dutton C, Zera C. Contraception and postpartum follow-up in patients with gestational diabetes. (1879–0518 (Electronic)).

  12. Perritt JB, Burke A, Jamshidli R, Wang J, Fox M. Contraception counseling, pregnancy intention and contraception use in women with medical problems: an analysis of data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception. 2013;88(2):263–8.

    Article  Google Scholar 

  13. Law DS, Tan CE, Tong SF. Influences on the decision to use contraception among Sarawakian women with diabetes: a qualitative exploration. Sex Reprod Health Matters. 2019;27(1):1571316.

    PubMed  Google Scholar 

  14. Britton LE, Berry DC, Crandell JL, Brooks JL, Bryant AG. Perceptions and behaviors related to contraceptive use in the postpartum period among women with pregestational diabetes Mellitus. J Obs Gynecol Neonatal Nurs: JOGNN. 2020;49(2):154–66.

    Article  Google Scholar 

  15. Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Womens Health Issues. 2005;15(4):167–73.

    Article  Google Scholar 

  16. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.

    Article  Google Scholar 

  17. Turner AM, Donelan EA, Kiley JW. Contraceptive options following gestational diabetes: current perspectives. Open Access J Contracept. 2019;10:41–53.

    Article  Google Scholar 

Download references

Funding

This was an unfunded study.

Author information

Authors and Affiliations

Authors

Contributions

RW contributed to the study conception, design, data collection and the first draft of the manuscript. PJ contributed to the study conception, design, data analysis, the final draft and revision of the manuscript. NP contributed to the study design, data collection and data analysis. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Preeyaporn Jirakittidul.

Ethics declarations

Conflict of interests

The authors declare that they have no competing interests.

Ethics approval and consent to participate

The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, and the study protocol was approved by the Siriraj Institutional Review Board. Written consent was waived due to the nature of the retrospective study design. All data were collected from previous hospital records.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Winaitammakul, R., Jirakittidul, P. & Pingkul, N. Documented contraceptive use after delivery in women with pre-gestational and gestational diabetes in Thailand: a single center study. Diabetol Int (2022). https://doi.org/10.1007/s13340-022-00586-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13340-022-00586-x

Keywords

  • Contraception
  • Postpartum
  • Gestational diabetes
  • Pre-existing diabetes
  • Pregnancy